4
Changes in Ownership
Mineralys Therapeutics, Inc. Filed Acc 0001933414-23-000061
Chief Executive Officer bought 2,000 shares at $12.89 ($25,780)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Congleton Jon Chief Executive Officer | 2023-08-11 | Purchase | +2,000 | $12.89 | $25,780 | 1,040,318 | D |
| Open-market purchases · 2,000 sh · avg $12.89 · $25,780 | |||||||
Loading xslF345X05/wf-form4_169179546088184.xml…